Infection, Inflammation and Rheumatology
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 140
Special Issue Editor
Interests: infection; inflammation; autoimmunity; various rheumatic diseases
Special Issue Information
Dear Colleagues,
We are excited to announce a forthcoming Special Issue that explores infection, inflammation, and rheumatology and investigates the intricate connections between the immune system, infections, and vaccinations that lead to inflammation and associated rheumatic conditions. This comprehensive edition aims to shed light on the latest advancements, challenges, and innovative approaches within this multifaceted landscape.
Infections and autoimmune responses, particularly in the context of COVID-19 and vaccinations, have underscored the complexities in diagnosis, treatment, and management. This Special Issue will delve into a range of autoimmune disorders, such as rheumatoid arthritis, lupus, and vasculitides, while emphasizing their underlying mechanisms, genetic predispositions, and possible links to infectious agents like COVID-19.
The Special Issue will showcase cutting-edge research methodologies, diagnostic tools, and therapeutic interventions aimed at enhancing patient outcomes. Contributions exploring novel biomarkers, personalized medicine approaches (including vaccination strategies), and emerging treatments (such as biologics and immunotherapies) will be pivotal in this discourse.
We invite researchers, clinicians, and experts in the field to contribute their insights, research findings, and perspectives to this Special Issue and unravel the complexities of autoimmune diseases in rheumatology, striving toward enhanced understanding, improved therapies, and better outcomes for affected individuals.
Dr. Arvind Nune
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infection
- COVID-19
- inflammation
- vaccination
- rheumatic diseases
